2-phenylaminoadenosine,
CV 1808,
CV-1808,
2-Phenylaminoadenosine,
53296-10-9,
CV-1808,
(2R,3R,4S,5R)-2-(6-Amino-2-(phenylamino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol,
CV 1808,
UNII-K40I59G1EF,
Adenosine, 2-(phenylamino)-,
K40I59G1EF,
CHEMBL1256672,
N6-Phenylado,
C16H18N6O4,
SMR000326899,
CV1808,
AC1OCEOA,
GTPL420,
MLS000860041,
MLS002153318,
SCHEMBL725689,
BDBM82022,
CTK8B9482,
(3R,4S,5R)-2-(6-Amino-2-anilino-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol,
HMS2235F09,
HMS3676D20,
2-(Phenylamino)ado (CV-1808),
ZINC3995405,
7561AB,
ANW-62591,
PDSP1_000996,
PDSP1_001206,
PDSP2_000980,
PDSP2_001190,
2-Phenylaminoadenosine, >97%, solid,
AKOS016004073,
NCGC00025270-02,
NCGC00025270-03,
AC-27396,
AJ-47602,
AX8233412,
TC-151336,
FT-0673725,
(2R,3R,4S,5R)-2-(6-amino-2-anilinopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol,
(2R,3R,4S,5R)-2-[6-amino-2-(phenylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol,
2-[6-Amino-2-(3-cyclohexyl-propylamino)-purin-9-yl]-5-hydroxymethyl-tetrahydro-furan-3,4-diol,
D06NRX,
C16-H18-N6-O4,
CID6917803,
C026708,